With the latest funds, private equity firm Petra has $14 million invested in Nashville-based SpecialtyCare, which is led by former Renal Care Group executive Gary Brukardt.
GETAHN WARDNodality Inc. raises $15.5M in financing
Nodality Inc., a San Francisco-based biotechnology company with a research and development laboratory in Franklin, said it has raised $15.5 million in a new round of financing.
Pfizer Ventures, an arm of Pfizer Inc., and Laboratory Corp. of America Holdings led the round. Other participants included Kleiner Perkins Caulfield & Byers, TPG Biotechnology and Maverick Capital, which like Pfizer previously had invested in Nodality.
Nodality focuses on developing the next generation of personalized medical tests for cancer and autoimmune disease treatments.
Nonresidential Construction Industry Continues to StruggleTake Part: Has your medical identity been stolen?